Moderna：ESMO回答了科学问题，Q3必须回答资金问题（纳斯达克：MRNA）
· seekingalpha.com
为什么Moderna仍是卖出：ESMO数据、估值风险、定价障碍以及即将到来的关键催化剂。
In my last article on Moderna ( MRNA ), I rated the stock a Sell and said that I would be looking at three things at ESMO , whether the hazard ratio comes in cl...